Open access · CC-BY
via OpenAlex
Low-dose naltrexone extends healthspan and lifespan in C. elegans via SKN-1 activation
Weisha Li, Rebecca L. McIntyre, Bauke V. Schomakers, Rashmi Kamble, Anne H.G. Luesink, Michel van Weeghel, Riekelt H. Houtkooper, Arwen W. Gao, Georges E. Janssens
iScience · 2024 · ▲ 4 citations
Abstract
As the global aging population rises, finding effective interventions to improve aging health is crucial. Drug repurposing , utilizing existing drugs for new purposes, presents a promising strategy for rapid implementation. We explored naltrexone from the Library of Integrated Network-based Cellular Signatures (LINCS) based on several selection criteria. Low-dose naltrexone (LDN) has gained attention for treating various diseases, yet its impact on longevity remains underexplored. Our study on C. elegans demonstrated that a low dose, but not high dose, of naltrexone extended the healthspan(definition) and lifespan. This effect was mediated through SKN-1 (NRF2 in mammals) signaling, influencing innate immune gene expression and upregulating oxidative stress responses. With LDN’s low side effects profile, our findings underscore its potential as a geroprotector, suggesting further exploration for promoting healthy aging in humans is warranted.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.isci.2024.109949
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Li, W., McIntyre, R.L., Schomakers, B.V., Kamble, R., Luesink, A.H., Weeghel, M.V., Houtkooper, R.H., Gao, A.W., & Janssens, G.E. (2024). Low-dose naltrexone extends healthspan and lifespan in C. elegans via SKN-1 activation. <em>iScience</em>. https://doi.org/10.1016/j.isci.2024.109949
Vancouver
Li W, McIntyre RL, Schomakers BV, Kamble R, Luesink AH, Weeghel MV, et al. Low-dose naltrexone extends healthspan and lifespan in C. elegans via SKN-1 activation. iScience. 2024. doi:10.1016/j.isci.2024.109949.
BibTeX
@article{weisha2024Lowdos,
title = {Low-dose naltrexone extends healthspan and lifespan in C. elegans via SKN-1 activation},
author = {Weisha Li and Rebecca L. McIntyre and Bauke V. Schomakers and Rashmi Kamble and Anne H.G. Luesink and Michel van Weeghel and Riekelt H. Houtkooper and Arwen W. Gao and Georges E. Janssens},
journal = {iScience},
year = {2024},
doi = {10.1016/j.isci.2024.109949},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Pharmacology 2024
Open access · CC-BY
Phloretic acid requires the insulin/IGF-1 pathway and autophagy to enhance stress resistance and extend the lifespan of Caenorhabditis elegans
International Journal of Molecular Sciences 2021
Open access · CC-BY
Ferulic Acid Supplementation Increases Lifespan and Stress Resistance via Insulin/IGF-1 Signaling Pathway in C. elegans
AgelessRx 2022
Open access · US-GOV
The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging - A Retrospective Cross-sectional Study Into Off-label Use of LDN
PLoS ONE 2011
Open access · CC-BY
Lifespan-Extending Effects of Royal Jelly and Its Related Substances on the Nematode Caenorhabditis elegans
Food & Function 2018
Citation only
Blueberry extract promotes longevity and stress tolerance via DAF-16 in Caenorhabditis elegans
Journal of Food Biochemistry 2025
Open access · CC-BY